Investments | Note 3 – Investments Available for Sale Securities – Fixed Maturity Securities The Company’s insurance subsidiary is regulated by insurance statutes and regulations as to the type of investments they are permitted to make, and the amount of funds that may be used for any one type of investment. Investments in available for sale securities are summarized as follows: September 30, 2022 Original or Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Investments available for sale: Fixed maturities U.S. Government and govt. agencies and authorities $ 21,313,155 $ 0 $ (1,198,869 ) $ 20,114,286 U.S. special revenue and assessments 7,536,507 0 (392,137 ) 7,144,370 All other corporate bonds 91,550,400 90,639 (8,921,730 ) 82,719,309 $ 120,400,062 $ 90,639 $ (10,512,736 ) $ 109,977,965 December 31, 2021 Original or Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Investments available for sale: Fixed maturities U.S. Government and govt. agencies and authorities $ 25,312,358 $ 355,623 $ (17,078 ) $ 25,650,903 U.S. special revenue and assessments 7,540,867 982,668 0 8,523,535 All other corporate bonds 95,096,738 11,692,705 0 106,789,443 $ 127,949,963 $ 13,030,996 $ (17,078 ) $ 140,963,881 The amortized cost and estimated market value of debt securities at September 30, 2022, by contractual maturity, is shown below. Expected maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Fixed Maturities Available for Sale September 30, 2022 Amortized Cost Fair Value Due in one year or less $ 8,496,905 $ 8,416,295 Due after one year through five years 44,881,107 42,688,475 Due after five years through ten years 17,950,439 17,078,456 Due after ten years 22,053,354 18,865,205 Fixed maturities with no single maturity date 27,018,257 22,929,534 Total $ 120,400,062 $ 109,977,965 The fair value of investments with sustained gross unrealized losses are as follows: September 30, 2022 Less than 12 months 12 months or longer Total Fair value Unrealized losses Fair value Unrealized losses Fair value Unrealized losses U.S. Government and govt. agencies and authorities $ 20,114,286 (1,198,869 ) 0 0 20,114,286 $ (1,198,869 ) U.S. Special Revenue and Assessments 7,144,370 (392,137 ) 0 0 7,144,370 (392,137 ) All other corporate bonds 78,415,980 (8,921,730 ) 0 0 78,415,980 (8,921,730 ) Total fixed maturities $ 105,674,636 (10,512,736 ) 0 0 105,674,636 $ (10,512,736 ) December 31, 2021 Less than 12 months 12 months or longer Total Fair value Unrealized losses Fair value Unrealized losses Fair value Unrealized losses U.S. Government and govt. agencies and authorities $ 4,042,825 (17,078 ) 0 0 4,042,825 $ (17,078 ) Total fixed maturities $ 4,042,825 (17,078 ) 0 0 4,042,825 $ (17,078 ) Additional information regarding investments in an unrealized loss position is as follows: Less than 12 months 12 months or longer Total As of September 30, 2022 Fixed maturities 58 0 58 As of December 31, 2021 Fixed maturities 3 0 3 Substantially all of the unrealized losses on fixed maturities at September 30, 2022 and December 31, 2021 are attributable to changes in market interest rates and general disruptions in the credit market subsequent to purchase. The Company does not currently intend to sell nor does it expect to be required to sell any of the securities in an unrealized loss position. Based upon the Company’s expected continuation of receipt of contractually required principal and interest payments and its intent and ability to retain the securities until price recovery, as well as the Company’s evaluation of other relevant factors, the Company deems these securities to be temporarily impaired as of September 30, 2022 and December 31, 2021. Net Investment Gains (Losses) The following table presents net investment gains (losses) and the change in net unrealized gains (losses) on investments. Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 Realized gains: Sales of fixed maturities $ 0 $ 21,631 $ 4,683 $ 55,867 Sales of equity securities 1,485,872 19,344 1,883,453 3,038,551 Sales of real estate 449,133 104,204 5,020,973 1,487,456 Total realized gains 1,935,005 145,179 6,909,109 4,581,874 Realized losses: Sales of fixed maturities 0 0 (5,210 ) 0 Sales of equity securities 0 (17,404 ) (109,636 ) (21,592 ) Sales of real estate (34,547 ) 0 (34,547 ) 0 Other-than-temporary impairments 0 18,129 0 (393,455 ) Total realized losses (34,547 ) 725 (149,393 ) (415,047 ) Net realized investment gains (losses) 1,900,458 145,904 6,759,716 4,166,827 Change in fair value of equity securities: Change in fair value of equity securities held at the end of the period 7,097,738 (9,380,710 ) 14,462,029 10,994,305 Change in fair value of equity securities 7,097,738 (9,380,710 ) 14,462,029 10,994,305 Net investment gains (losses) $ 8,998,196 $ (9,234,806 ) $ 21,221,745 $ 15,161,132 Change in net unrealized gains (losses) on available-for-sale investments included in other comprehensive income: Fixed maturities $ (7,122,856 ) $ (1,186,410 ) $ (23,436,431 ) $ (6,161,411 ) Net increase (decrease) $ (7,122,856 ) $ (1,186,410 ) $ (23,436,431 ) $ (6,161,411 ) Other-Than-Temporary Impairments The Company regularly reviews its investment securities for factors that may indicate that a decline in fair value of an investment is other than temporary. The factors considered by Management in its regular review to identify and recognize other-than-temporary impairment losses on fixed maturities include, but are not limited to: the length of time and extent to which the fair value has been less than cost; the Company’s intent to sell, or be required to sell, the debt security before the anticipated recovery of its remaining amortized cost basis; the financial condition and near-term prospects of the issuer; adverse changes in ratings announced by one or more rating agencies; subordinated credit support, whether the issuer of a debt security has remained current on principal and interest payments; current expected cash flows; whether the decline in fair value appears to be issuer specific or, alternatively, a reflection of general market or industry conditions, including the effect of changes in market interest rates. If the Company intends to sell a debt security, or it is more likely than not that it would be required to sell a debt security before the recovery of its amortized cost basis, the entire difference between the security’s amortized cost basis and its fair value at the balance sheet date would be recognized by a charge to other-than-temporary losses in the Condensed Consolidated Statements of Operations. Management regularly reviews its real estate portfolio in comparison to appraisal valuations and current market conditions for indications of other-than-temporary impairments. If a decline in value is judged by Management to be other-than-temporary, a loss is recognized by a charge to other-than-temporary impairment losses in the Condensed Consolidated Statements of Operations. The Company did not recognize any other-than-temporary impairments during the nine months ended September 30, 2022. The Company recognized an other-than-temporary impairment on one fixed maturity security during the second quarter of 2021. The other-than-temporary impairment was recognized due to the length of time the investment remained in an unrealized loss position. Cost Method Investments The Company held equity investments with an aggregate cost of $13,683,343 and 14,543,343 at September 30, 2022 and December 31, 2021, respectively. These equity investments were not reported at fair value because it is not practicable to estimate their fair values due to insufficient information being available. Management did not identify any events or changes in circumstances that might have a significant adverse effect on the reported value of those investments. Based on Management’s evaluation of the expected cash flow of the investments, and the Company’s ability and intent to hold the investments for a reasonable period of time, the Company does not deem an other-than-temporary impairment necessary at September 30, 2022. Trading Securities Securities designated as trading securities are reported at fair value, with gains or losses resulting from changes in fair value recognized in net investment income on the Condensed Consolidated Statements of Operations. Trading securities include exchange-traded equities and exchange-traded options. Trading securities carried as liabilities are securities sold short. A gain, limited to the price at which the security was sold short, or a loss, potentially unlimited in size, will be recognized upon the termination of the short sale. The fair value of derivatives included in trading security assets and trading security liabilities as of September 30, 2022 was $0. The fair value of derivatives included in trading security assets and trading security liabilities as of December 31, 2021 was $0 and $1,116, respectively. Earnings from trading securities are classified in cash flows from operating activities. The derivatives held by the Company are for income generation purposes only. Trading revenue charged to net investment income from trading securities was: Three Months Ended September 30, 2022 2021 Net unrealized gains (losses) $ 0 $ 379 Net realized gains (losses) 0 2,056 Net unrealized and realized gains (losses) $ 0 $ 2,435 Nine Months Ended September 30, 2022 2021 Net unrealized gains (losses) $ 0 $ 1,329 Net realized gains (losses) (13,283 ) 20,360 Net unrealized and realized gains (losses) $ (13,283 ) $ 21,689 Mortgage Loans The Company, from time to time, acquires mortgage loans through participation agreements with FSNB. FSNB has been able to provide the Company with additional expertise and experience in underwriting commercial and residential mortgage loans, which provide more attractive yields than the traditional bond market. The Company is able to receive participations from FSNB for three primary reasons: 1) FSNB has already reached its maximum lending limit to a single borrower, but the borrower is still considered a suitable risk; 2) the interest rate on a particular loan may be fixed for a long period that is more suitable for UG given its asset-liability structure; and 3) FSNB’s loan growth might at times outpace its deposit growth, resulting in FSNB participating such excess loan growth rather than turning customers away. For originated loans, the Company’s Management is responsible for the final approval of such loans after evaluation. Before a new loan is issued, the applicant is subject to certain criteria set forth by Company Management to ensure quality control. These criteria include, but are not limited to, a credit report, personal financial information such as outstanding debt, sources of income, and personal equity. Once the loan is approved, the Company directly funds the loan to the borrower. The Company bears all risk of loss associated with the terms of the mortgage with the borrower. During the nine months ended September 30, 2022 and 2021, the Company acquired $1,755,496 and $3,305,354 in mortgage loans, respectively. FSNB services the majority of the Company’s mortgage loan portfolio. The Company pays FSNB a 0.25% servicing fee on these loans and a one-time fee at loan origination of 0.50% of the original loan cost to cover costs incurred by FSNB relating to the processing and establishment of the loan. During 2022 and 2021, the maximum and minimum lending rates for mortgage loans were: 2022 2021 Maximum rate Minimum rate Maximum rate Minimum rate Farm Loans 6.00 % 4.50 % 6.00 % 4.50 % Commercial Loans 6.00 % 4.10 % 5.50 % 4.10 % Residential Loans 5.00 % 4.15 % 5.00 % 4.15 % Most mortgage loans are first position loans. Loans issued are generally limited to no more than 80% of the appraised value of the property. The Company has in place a monitoring system to provide Management with information regarding potential troubled loans. Letters are sent to each mortgagee when the loan becomes 30 days or more delinquent. Management is provided with a monthly listing of loans that are 60 days or more past due along with a brief description of what steps are being taken to resolve the delinquency. All loans 90 days or more past due are placed on a non-performing status and classified as delinquent loans. Quarterly, coinciding with external financial reporting, the Company reviews each delinquent loan and determines how each delinquent loan should be classified. Management believes the current internal controls surrounding the mortgage loan selection process provide a quality portfolio with minimal risk of foreclosure and/or negative financial impact. Changes in the current economy could have a negative impact on the loans, including the financial stability of the borrowers, the borrowers’ ability to pay or to refinance, the value of the property held as collateral and the ability to find purchasers at favorable prices. Interest accruals are analyzed based on the likelihood of repayment. In no event will interest continue to accrue when accrued interest along with the outstanding principal exceeds the net realizable value of the property. The Company does not utilize a specified number of days delinquent to cause an automatic non-accrual status. A mortgage loan reserve is established and adjusted based on Management’s quarterly analysis of the portfolio and any deterioration in value of the underlying property which would reduce the net realizable value of the property below its current carrying value. The mortgage loan reserve was $0 at September 30, 2022 and December 31, 2021. The following table summarizes the mortgage loan holdings of the Company for the periods ended: September 30, 2022 December 31, 2021 In good standing $ 27,424,166 $ 27,102,789 Overdue interest over 90 days 2,080,773 2,080,773 Total mortgage loans $ 29,504,939 $ 29,183,562 Investment Real Estate Real estate held-for-investment is stated at cost less accumulated depreciation. Depreciation is computed on a straight-line basis for financial reporting purposes using estimated useful lives of 3 to 30 years. The Company periodically reviews its real estate held-for-investment for impairment and tests for recoverability whenever events or changes in circumstances indicate the carrying value may not be recoverable. During the nine months ended September 30, 2022, no impairments were recognized on the investment real estate. Note 4 - Fair Value Measurements of the Condensed Consolidated Financial Statements provides further information regarding the fair value of financial instruments that are not measured at fair value. The investment real estate owned by the Company is included in this portion of the Note 4 - Fair Value Measurements disclosure. The following table provides an allocation of the Company’s investment real estate by type: September 30, 2022 December 31, 2021 Raw land $ 12,365,607 $ 14,538,507 Commercial 5,185,507 4,347,423 Residential 3,618,791 3,813,936 Land, minerals and royalty interests 14,778,653 17,048,395 Total investment real estate $ 35,948,558 $ 39,748,261 The Company’s investment real estate portfolio includes ownership in oil and gas royalties. As of September 30, 2022 and December 31, 2021, investments in oil and gas royalties represented 41% and 43%, respectively, of the total investment real estate portfolio. See Note 9 – Concentrations of Credit Risk of the Condensed Consolidated Financial Statements for additional information regarding the allocation of the oil and gas investment real estate holdings by industry type. Gains and losses recognized on the disposition of the properties are recorded as realized gains and losses in the Condensed Consolidated Statements of Operations. During the nine months ended September 30, 2022 and 2021, the Company acquired $4,236,603 and $5,507,777 of investment real estate, respectively. Notes Receivable Notes receivable represent collateral loans and promissory notes issued by the Company and are reported at their unpaid principal balances, adjusted for valuation allowances. Valuation allowances are established for impaired loans when it is probable that contractual principal and interest will not be collected. The valuation allowance as of September 30, 2022 and December 31, 2021 was $0. Interest accruals are analyzed based on the likelihood of repayment. The Company does not utilize a specified number of days delinquent to cause an automatic non-accrual status. During the nine months ended September 30, 2022 and 2021 the Company acquired $5,870,657 and $7,840,000 of notes receivable, respectively. Before a new note is issued, the applicant is subject to certain criteria set forth by Company Management to ensure quality control. Once the note is approved, the Company directly funds the note to the borrower. Several of the notes have participation agreements in place, whereas the Company has reduced its investment in the note receivable by participating a portion of the note to a third party. Similar to the mortgage loans, FSNB services several of the notes receivable. The Company, and the participants in the notes, share in the risk of loss associated with the terms of the note with the borrower, based upon their ownership percentage in the note. The Company has in place a monitoring system to provide Management with information regarding potential troubled loans. |